HERBALIFE LTD. — Form 8-K
Filed November 2, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 48/100
What the filing says
Herbalife reported Q3 2026 net sales of $1.35B (+6.0% YoY; +7.6% constant currency), adjusted EBITDA of $182.4M (13.5% margin, +70bps YoY), and adjusted diluted EPS of $0.64 (+$0.14 YoY). Board authorized a new $250M share repurchase program over three years. Scott Schaefer was appointed CFO effective November 1, 2026, and John DeSimone became interim CEO. Net leverage improved to 2.0x from 2.2x. Full-year 2026 net sales guidance raised; adjusted EBITDA guidance maintained on reported basis.
Why this rating
Solid Q3 growth and margin expansion is ordinary; $250M buyback (33% of market cap) and CFO/CEO transition are material corporate actions but execution risk is high given ongoing CEO search.
See more from November 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.